[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:notch2-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"NOTCH2 Gene",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06357676","Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:02.712396Z","2026-05-05T02:43:28.817702Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07257055","Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study",[19],"Phase 2","2026-08-26T02:18:12.612955Z","2026-05-05T02:43:27.813302Z"]